New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 4.5 miu - powder for injection - 4.5 miu - active: interferon alfa-2a 4.5 miu excipient: albumin sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 6 miu - powder for injection - 6 miu - active: interferon alfa-2a 6 miu excipient: albumin sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 9 miu - powder for injection - 9 miu - active: interferon alfa-2a 9 miu excipient: albumin sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 30 miu/ml (final fill volume, 0.72 ml, includes a 20 % fill overage); ribavirin 200mg;   - combination - 18 miu/0.6 ml, 200 mg - active: interferon alfa-2a 30 miu/ml (final fill volume, 0.72 ml, includes a 20 % fill overage) excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection active: ribavirin 200mg   excipient: ethylcellulose as aqueous dispersion (solids) hypromellose as component of opadry 03a14309 pink iron oxide red as component of opadry 03a14309 pink iron oxide yellow as component of opadry 03a14309 pink magnesium stearate maize starch microcrystalline cellulose purified talc as component of opadry 03a14309 pink sodium starch glycolate starch titanium dioxide as component of opadry 03a14309 pink triacetin

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 6 miu/ml; ribavirin 200mg;   - combination - 3miu/0.5ml, 200mg - active: interferon alfa-2a 6 miu/ml excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection active: ribavirin 200mg   excipient: ethylcellulose hypromellose as component of opadry 03a14309 pink iron oxide red as component of opadry 03a14309 pink iron oxide yellow as component of opadry 03a14309 pink magnesium stearate maize starch microcrystalline cellulose purified talc as component of opadry 03a14309 pink sodium starch glycolate starch titanium dioxide as component of opadry 03a14309 pink triacetin

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - interferon alfa 2a 3 miu / 0.5 ml - solution for injection - interferon alfa-2a - condylumata acuminata. hepatitis b,c. hairy cell leukemia. cml. aids related kaposis sarcoma. renal cell carcinoma.follicular non-hodgkin's lymphoma. patients with ajcc stage ii malignant melanoma (breslow tumour thickness > 1.5 mm, no lymph node involvement or cutaneous spread) who are free of disease after surgery.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

recombinant interferon alpha2a; human serum albumin-5mg;sodium chloride-9mg

Egypt - English - EDA (Egyptian Drug Authority)

f.hoffman la roche-scientific office - injection - 3 m.i.u.

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - interferone alfa - injection - 3